Stockscreener 앱 받기
1.50
2.60%
-0.04
전일 마감가:
$1.54
열려 있는:
$1.58
하루 거래량:
38,544
Relative Volume:
0.24
시가총액:
$3.34M
수익:
$3.35M
순이익/손실:
$-25.31M
주가수익비율:
-0.041
EPS:
-36.5794
순현금흐름:
$-24.29M
1주 성능:
+5.63%
1개월 성능:
-9.64%
6개월 성능:
-90.64%
1년 성능:
-95.62%
1일 변동 폭
$1.4801
$1.6252
1주일 범위
$1.32
$1.6252
52주 변동 폭
$1.26
$35.00
Geovax Labs Inc Stock (GOVX) Company Profile
명칭
Geovax Labs Inc
전화
678-384-7220
주소
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
1.50 | 3.42M | 3.35M | -25.31M | -24.29M | -36.58 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-04-15 | 재확인 | Alliance Global Partners | Buy |
| 2025-04-15 | 재확인 | D. Boral Capital | Buy |
| 2024-11-11 | 개시 | Alliance Global Partners | Buy |
| 2024-07-16 | 개시 | ROTH MKM | Buy |
| 2020-11-19 | 개시 | Maxim Group | Buy |
모두보기
Geovax Labs Inc 주식(GOVX)의 최신 뉴스
GeoVax Advances Mpox and Smallpox Vaccine Toward Phase 3 Trial with Clinical Supply Milestone - citybuzz -
GeoVax Provides Update on GEO-MVA Program - Yahoo Finance
Ideas Watch: Is GeoVax Labs Inc Equity Warrants ROE strong enoughPortfolio Performance Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
GeoVax Labs Inc expected to post a loss of $6.17 a shareEarnings Preview - TradingView
Certain Warrants of GeoVax Labs, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
If You Invested $1,000 in Geovax Labs Inc (GOVX) - Stock Titan
Published on: 2026-03-22 08:06:31 - baoquankhu1.vn
Loss Report: Does GeoVax Labs Inc Equity Warrant stock benefit from AI growth2026 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Stock Analysis: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategy2026 Closing Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Short Squeeze: What is First Horizon Corporations debt to equity ratioProduct Launch & Daily Stock Trend Watchlist - baoquankhu1.vn
Pharma News: Is GeoVax Labs Inc Equity Warrants ROE strong enough2026 Stock Rankings & Weekly High Conviction Ideas - baoquankhu1.vn
GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine for Immunocompromised Patients - Yahoo Finance
GeoVax Engages Global Health Organizations for Future Mpox/Smallpox Vaccine Procurement - citybuzz -
How The Story On GeoVax Labs (GOVX) Is Shifting Toward Execution Risk And Funding Constraints - Yahoo Finance
GeoVax Initiates Outreach Regarding Future Procurement of GEO-MVA Mpox/Smallpox Vaccine - Yahoo Finance
GOVXW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Entry Recap: Can GeoVax Labs Inc. navigate macro headwinds2026 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
Aug Decliners: Is GeoVax Labs Inc Equity Warrant benefiting from interest rate changes2025 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
Update Recap: Is GeoVax Labs Inc Equity Warrant gaining market share2025 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug Fed Impact: Is GeoVax Labs Inc Equity Warrant stock technically oversold2025 Breakouts & Breakdowns & Weekly Top Gainers Alerts - baoquankhu1.vn
GeoVax Labs Inc. (NASDAQ:GOVX) Sees Significant Decline in Short Interest - Defense World
Can POET Technologies Inc keep up with sector leaders2025 Price Targets & Long-Term Growth Portfolio Plans - baoquankhu1.vn
GOVX SEC FilingsGeovax Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
GOVXW SEC FilingsGeovax Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Performance Recap: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockJuly 2025 EndofMonth & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Insider Trends: Will GeoVax Labs Inc benefit from geopolitical trendsJuly 2025 Action & Risk Controlled Swing Alerts - baoquankhu1.vn
GOVX PE Ratio & Valuation, Is GOVX Overvalued - Intellectia AI
GOVX Should I Buy - Intellectia AI
GOVX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Hedge Fund Bets: What is Cross Country Healthcare Incs valuation compared to sectorGap Up & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Treasury Yields: Is GeoVax Labs Inc Equity Warrant a strong candidate for buy and holdInsider Buying & Advanced Technical Analysis Signals - baoquankhu1.vn
GeoVax Forms Oncology Advisory Board to Guide Gedeptin Development in Solid Tumors - citybuzz -
GeoVax Announces Oncology Advisory Board to Advance Gedeptin(R) Development Across Solid Tumors - Yahoo Finance
GOVX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Final Week: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategy2025 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn
GOVX Stock Price, Forecast & Analysis | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
Bull Bear: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockTake Profit & Weekly Return Optimization Alerts - baoquankhu1.vn
GeoVax Labs downgraded to Hold from Buy at D. Boral Capital - TipRanks
D. Boral Capital downgrades GeoVax Labs stock rating to Hold - Investing.com Nigeria
D. Boral Capital downgrades GeoVax Labs stock rating to Hold By Investing.com - Investing.com South Africa
Geovax Labs (GOVX) Receives Downgrade to 'Hold' by D. Boral Capi - GuruFocus
GeoVax Expands Immuno-Oncology Portfolio with Exclusive License for Gedeptin Combination Technology - citybuzz -
GeoVax Expands Immuno-Oncology Strategy with Exclusive License for Gedeptin Combination Technology - citybuzz -
GeoVax Secures Exclusive License for Gedeptin(R) + Immune Checkpoint Inhibitor Combination Technology - Yahoo Finance
Dow Update: Will GeoVax Labs Inc outperform the market in YEARJuly 2025 Setups & Reliable Breakout Forecasts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
GeoVax Labs Announces Financing Through Equity Offerings - TipRanks
GeoVax Raises ~$0.87M at $2.31 in Registered Direct Offering, Adds Private Warrants - TradingView
GeoVax Endorses Global Call for Sustained Mpox Response, Highlights Vaccine Program Readiness - citybuzz -
GeoVax Endorses Global Call to Sustain Mpox Response as Evidence Confirms Epidemic Is Far From Over - TradingView
GeoVax Labs Inc. (NASDAQ:GOVX) Short Interest Update - Defense World
Geovax Labs Inc (GOVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):